1 COVID-19 - what should anaethesiologists and intensivists know about it?

2 COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.

3 Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China.

4 Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

5 Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020.

6 Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?

7 WHO Declares COVID-19 a Pandemic.

8 COVID-19 pandemic: Radiotherapy precautions and preparedness

9 Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters

10 Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

11 COVID-19: combining antiviral and anti-inflammatory treatments

12 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

13 Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

14 Impact of COVID-19 on people with cystic fibrosis

15 Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis

16 Low incidence of COVID-19 in children and adolescent post-liver transplant at a Latin American reference center

17 The COVID-19 Pandemic from an Ophthalmologist's Perspective

18 The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

19 A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features

20 COVID-19 and Nasal Cytobrush Cytology

21 Smell and taste dysfunction in patients with COVID-19

22 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

23 Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis

24 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

25 Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

26 Hydroxychloroquine prophylaxis for COVID-19 contacts in India

27 Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

28 Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

29 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

30 A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

31 Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020

32 Understanding Unreported Cases in the COVID-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions.

33 [A pathological report of three COVID-19 cases by minimally invasive autopsies].

34 Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.

35 Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

36 Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT.

37 Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.

38 Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVID-19.

39 Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.

40 Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.

41 Should patients stop their biologic treatment during the COVID-19 pandemic.

42 From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach

43 Iranian mental health during the COVID-19 epidemic

44 Clinical considerations for patients with diabetes in times of COVID-19 epidemic

45 Traditional Chinese medicine for COVID-19 treatment

46 Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

47 Of chloroquine and COVID-19

48 Diabetes and COVID-19

49 How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know

50 The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy

51 Are high-performing health systems resilient against the COVID-19 epidemic?

52 Looming threat of COVID-19 infection in Africa: act collectively, and fast

53 Lessons for managing high-consequence infections from first COVID-19 cases in the UK

54 Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study

55 One world, one health: The novel coronavirus COVID-19 epidemic

56 Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19

57 Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020

58 What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures?

59 Global spread of COVID-19 and pandemic potential

60 Going viral – Covid-19 impact assessment: A perspective beyond clinical practice

61 Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.

62 SARS-CoV-2 and COVID-19: The most important research questions.

63 There may be virus in conjunctival secretion of patients with COVID-19.

64 Internationally lost COVID-19 cases.

65 Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

66 Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19.

67 Undocumented U.S. Immigrants and Covid-19.

68 Artificial Intelligence and Machine Learning to Fight COVID-19.

69 Consensus guidelines for managing the airway in patients with COVID-19.

70 [Dealing with psychological distress by healthcare professionals during the COVID-19 pandemia].

71 A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).

72 The versatile heparin in COVID-19.

73 Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".

74 A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs.

75 Complex emergencies of COVID-19: management and experience in Zhuhai.

76 Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic.

77 Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department.

78 The COVID-19 Intubation and Ventilation Pathway (CiVP); a Commentary.

79 Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.

80 Emerging prophylaxis strategies against COVID-19.

81 The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19

82 [Comparison of two epidemic patterns of COVID-19 and evaluation of prevention and control effectiveness: an analysis based on Guangzhou and Wenzhou].

83 [Epidemiological characteristics of COVID-19 in Shaanxi province].

84 Considerations on Colorectal Cancer Care in a COVID-19 Pandemic Epicenter.

85 Why are pregnant women susceptible to COVID-19? An immunological viewpoint.

86 SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.

87 Active Surveillance for Suspected COVID-19 Cases in Inpatients with Information Technology.

88 Ark of Life and Hope：Role of Cabin Hospital in Facing COVID-19.

89 Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers.

90 Safety of Ibuprofen in Patients with COVID-19; Causal or Confounded?

91 C-reactive protein levels in the early stage of COVID-19.

92 A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore.

93 Running a virtual allergy division and training program in the time of COVID-19 pandemic.

94 Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

95 Clinical observation and management of COVID-19 patients

96 Epidemiological data from the COVID-19 outbreak, real-time case information

97 Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province

98 Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak

99 Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms

100 Screening for Chinese medical staff mental health by SDS and SAS during the outbreak of COVID-19

101 Facial mask: A necessity to beat COVID-19

Keyword Connections

Journals

Research Groups

Bibliographies